Experimental integrase inhibitor GSK-572 shows continued promise
Early treatment for infants cheaper than delaying treatment, CHER study shows
Ugandan study shows why human rights are central to HIV prevention with African men who have sex with men
Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects
Hepatitis C epidemic in HIV-positive gay men in Netherlands seems to have levelled off
Incentives and phone follow-up could improve healthy behaviour by young people: more research needed
The future of AIDS activism: looking for sustained energy and new tactics 10 years after Durban
People with HIV/hepatitis C co-infection more likely to develop osteoporosis
